MLAB · Mesa Laboratories Inc · Fails to Deliver
$128.40
+3.24 (+2.59%)
At close · Oct 21
View the 10-K filed Jun 3, 2026
Return incl. dividend (before tax)
Customer concentration
— top customer 20% of revenue
One customer — 20% of revenue (fiscal 2026)
“In our Clinical Genomics division, a significant portion of revenues is generated from ongoing purchases by a relatively small number of established customers, with a single customer accounting for approximately 20% of the division's revenues in fiscal 2026.”
Market Cap
$700.38M
Shares
5.60M
Volume · Oct 21
53.13K
Avg daily vol (3M)
133.1K
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-09-24 | 246 | $133.01 | $32,720 |
| 2026-09-18 | 11 | $127.14 | $1,399 |
| 2026-09-03 | 5,200 | $130.65 | $679,380 |
| 2026-09-02 | 5,199 | $125.47 | $652,319 |
| 2026-08-28 | 1,366 | $128.65 | $175,736 |
| 2026-08-27 | 1,614 | $127.15 | $205,220 |
| 2026-08-21 | 218 | $119.15 | $25,975 |
| 2026-08-20 | 103 | $119.72 | $12,331 |
| 2026-08-04 | 12 | $104.43 | $1,253 |
| 2026-08-03 | 140 | $100.81 | $14,113 |
| 2026-07-31 | 216 | $101.04 | $21,825 |
| 2026-07-29 | 898 | $101.10 | $90,788 |
Showing 1–12 of 12 settlements
Key facts
CIK
724004
CUSIP
59064R109
13F (30d)
17 filings
17 filers
Visit website
Investor relations